U.S. Medical Equipment Stock News

NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

How Korea Factory Expansion Will Impact Axcelis Stock Investors

Axcelis Technologies plans to invest US$35 million in a new 200,000 square foot ion implantation equipment manufacturing facility in Pyeongtaek, Korea, integrating warehousing, cleanrooms, and training to support faster customer response, with production targeted to start in the second half of 2028. The planned Korean plant gives Axcelis Technologies another manufacturing hub in a key semiconductor region, which could help align its ion implantation capacity with AI driven advanced packaging...
NYSE:CE
NYSE:CEChemicals

Celanese (CE) Adds Board Veteran As Fair Value Narrative Stays In Focus

Board change puts fresh spotlight on Celanese Celanese (CE) has drawn fresh attention after electing industry veteran Luis Fernandez-Moreno to its Board of Directors, a move investors are interpreting as a sign of ongoing strategic development. Recent moves at Celanese sit against a mixed backdrop, with the share price gaining 11.03% year to date and a 4.84% 1 month share price return, while the 3 year total shareholder return has fallen 61.52% and the 5 year total shareholder return is down...
NYSE:NEM
NYSE:NEMMetals and Mining

How Fourmile Dispute Resolution At Newmont Stock Has Changed Its Investment Story

Newmont recently resolved its Fourmile project dispute with Barrick Mining and benefited from a rebound in gold prices following the latest Federal Reserve interest rate decision. This eased project uncertainty and reinforced its balance sheet flexibility. The cleared overhang at Fourmile reduces execution risk for Newmont's growth pipeline and supports its capacity to maintain shareholder distributions from internal cash generation. We will assess how Newmont's investment narrative is...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Palantir (PLTR) Lands First Aviation OperatorOS Deal As UK Hire Raises NHS Focus

Palantir Technologies (NasdaqGS:PLTR) signed its first commercial OperatorOS deal with Surf Air Mobility in the aviation sector. Surf Air Mobility will use OperatorOS as a commercial operating system, with both companies targeting wider adoption across aviation customers. Palantir hired former UK Labour deputy leader Tom Watson into a UK executive role while its NHS contract faces growing political criticism. These OperatorOS and NHS developments only capture part of Palantir's wider risk...
NYSE:FCX
NYSE:FCXMetals and Mining

Is Freeport McMoRan (FCX) Still Undervalued After Copper Price Swings?

Freeport-McMoRan has delivered a powerful share price run in recent years, and the latest swings in copper markets now put fresh focus on whether that move lines up with the cash the business can generate. With the stock trading around US$70.85 at the last close, the key issue for you is how that price stacks up against the underlying stream of future cash flows from its copper portfolio. Over the past 5 years, Freeport-McMoRan has returned about 136.4%, which raises the question of how much...
NasdaqGS:ARXS
NasdaqGS:ARXSAerospace & Defense

Lockheed Martin Stock And Defense Suppliers Worth A Closer Look

Fresh headlines around a proposed US$24.3b F-35 sale to Saudi Arabia have pushed defense back into the spotlight, with Lockheed Martin, RTX and their peers suddenly front and center in global politics and portfolio debates. Investor money often moves first when long-term contracts are in play, and hesitates when Washington scrutiny rises. This article walks through three U.S. large-cap defense stocks exposed to this news and explains why each might deserve a closer look. The three stocks...
NYSE:PSA
NYSE:PSASpecialized REITs

Public Storage (PSA) Stock Could Be 34% Undervalued Despite Steady Cash Flow

Public Storage has delivered a 29.0% share price gain over the past 3 years, which puts a spotlight on what investors are really paying for in terms of its future cash flows. With the stock recently closing at US$300.76, the question is how that price lines up with what the underlying business can generate in cash over time. A 29.0% return over 3 years means holders have already seen a solid payoff. Fresh buyers need to ask how much of the company’s future cash generation may already be...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

Nvidia AI Deal Might Change The Case For Investing In IREN (IREN)

IREN has pivoted from Bitcoin mining toward a vertically integrated AI cloud platform, anchored by a five year, roughly US$5.50b partnership with Nvidia and supported by large multiyear AI compute contracts. The shift means IREN’s operations are increasingly tied to data center build out, GPU supply constraints, and execution on high value AI cloud services rather than cryptocurrency cycles. The focus will now be on how IREN’s investment narrative is shaped by this Nvidia backed AI cloud...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Is Illumina (ILMN) Fully Valued After Its 30% Monthly Rally?

Illumina (ILMN) has drawn fresh attention after a strong recent share move, with the stock up 7.1% in a day and about 30% over the past month. Short-term momentum around Illumina is strong, with a 30-day share price return of 30.2% helping lift the year-to-date gain to 82.5%. The 1-year total shareholder return of 138.0% contrasts with a 5-year total shareholder return that is still down 41.8%. Scan beyond Illumina's surge and explore other fast-moving opportunities with our curated list of...
NYSE:IFF
NYSE:IFFChemicals

Why Is International Flavors & Fragrances (IFF) Pushing Into Dairy Feed Enzymes?

International Flavors & Fragrances (NYSE:IFF) has launched Omni-Bos™ PHY, a new phytase enzyme aimed at dairy cattle nutrition. The product is designed for ruminants, targeting feed efficiency and sustainability in a segment where phytase use has lagged poultry and swine. IFF is initially rolling out Omni-Bos™ PHY in selected emerging markets that management views as important for animal nutrition demand. IFF's launch of Omni-Bos™ PHY in dairy cattle feed is a meaningful move that investors...
NYSE:BAC
NYSE:BACBanks

Bank Of America (BAC) Adds Automated Tax Aware Investing Tools At Merrill

Bank of America (NYSE:BAC) unit Merrill introduced new automated tools for tax-efficient portfolio transitions and systematic cash investing within its advisory program. The Merrill rollout targets wealth management clients who want portfolio adjustments and cash deployment to follow preset, tax-aware rules. The automation is integrated into Merrill's existing investment advisory platform so advisers can apply these settings across eligible client accounts. Merrill's new tax-efficient...
NYSE:IDT
NYSE:IDTTelecom

Is IDT (IDT) Trading At A Premium To Its Cash Flow?

IDT Corporation has seen a sharp change in investor fortunes over the past few years, and the question now is whether the current US$69.05 share price lines up with the cash flows the business can generate. With the focus squarely on what the stock might be worth on a cash flow basis, the market story and the intrinsic value story may not be perfectly aligned. Over the past 3 years the stock has returned about 210.9%, which puts a lot of weight on whether those gains are supported by the...
NYSE:SYK
NYSE:SYKMedical Equipment

What Is Stryker (SYK) Signalling With Its New Foot And Ankle Tech?

Stryker (NYSE:SYK) introduced Prophecy Surgical Planning for its Incompass Total Ankle System at the AOFAS 2026 meeting on 17 September 2026. The Prophecy platform adds preoperative surgical planning and 3D visualization tools tailored to Stryker's Incompass Total Ankle implants. Stryker also unveiled the Hoffmann LRF smartHEX, a connected external fixation system designed for deformity correction and complex foot and ankle cases. The launch of Prophecy Surgical Planning and Hoffmann LRF...
NYSE:WH
NYSE:WHHospitality

Wyndham Hotels & Resorts (WH) Launches Dolce Nova, Is The Stock Too Pricey?

Wyndham Hotels & Resorts launches Dolce Nova brand Wyndham Hotels & Resorts (WH) has introduced Dolce Nova, an upper upscale extension of its Dolce Hotels & Resorts line, aimed at travelers seeking experience led, personalized stays and a stronger focus on wellbeing. Recent trading tells a mixed story. Wyndham Hotels & Resorts has a 1 day share price return of 1.47% and a 7 day share price return of 0.80%. However, the 90 day share price return has fallen 17.85% while the 1 year total...
NYSE:PFSI
NYSE:PFSIDiversified Financial

PennyMac Financial Services (PFSI) Stock Could Be 42% Undervalued On Rosen Law Firm Probe

PennyMac Financial Services has seen its share price fall sharply in 2026, and that slump puts a spotlight on whether the returns it earns on its capital really support where the stock trades today. With legal scrutiny also in view, investors are weighing how the company’s capital allocation record lines up with the current market tag. The share price is down 49.4% year to date, which raises a direct question about how strongly PennyMac’s returns on capital are being valued by the...
NYSE:BKV
NYSE:BKVOil and Gas

Is BKV (BKV) Undervalued After Its $500 Million Convertible Bond Offering?

BKV (BKV) recently completed a US$500 million convertible bond offering with 1.625% notes due October 15, 2031, a financing move that gives investors another lens on the company’s balance sheet and capital plans. BKV’s recent financing and Barnett Shale acquisitions arrive after a softer share price patch, with the stock down 16.95% on a year to date share price return. Even so, the 1 year total shareholder return of 2.70% remains slightly positive, suggesting momentum has faded while...
NYSE:VST
NYSE:VSTRenewable Energy

Vistra (VST) Shares Moved, What Is Driving Attention Now?

Vistra (VST) has drawn fresh attention after filing an omnibus shelf registration for common and preferred stock, a move that gives the utility more flexibility to respond to AI driven power demand and financing needs. Vistra’s share price has pulled back from earlier highs, with a 90 day share price return that declined 12.33% and a year to date share price return down 13.12%, even though the 3 year total shareholder return is around 3.4x and the 5 year total shareholder return is close to...
NasdaqGS:PCVX
NasdaqGS:PCVXBiotechs

What Vaxcyte (PCVX)'s Faster Trial Data Means For Shareholders

Vaxcyte recently advanced its timeline for topline data from the pivotal VAX-31 adult Phase 3 OPUS-1 trial to the end of October and appointed two veteran executives to its C-suite with deep experience in pneumococcal vaccines and regulatory approvals. This combination of an earlier clinical readout and added leadership with direct familiarity with competing vaccines reflects how Vaxcyte is trying to address execution risk around late stage development, regulatory filings and eventual...
NasdaqGS:IQ
NasdaqGS:IQEntertainment

How Global AI Contest Will Impact iQIYI Stock

iQIYI recently launched the Global AI Creator Challenge on the international version of its NadouPro platform, pairing it with Alibaba's Wan3.0 model. The initiative includes detailed submission rules, a prize pool above US$10,000, and a judging schedule that runs through late September 2026. The contest and NadouPro upgrades highlight iQIYI's push to embed AI into professional content workflows, which could influence production costs, creator engagement, and the appeal of its broader...
NYSE:GME
NYSE:GMESpecialty Retail

GameStop (GME) Posts Record Operating Income, Is It Still 90% Undervalued?

GameStop (GME) is back in focus after fresh Q2 2026 numbers showed record operating income alongside a sharp mix shift toward collectibles, paired with sizeable insider buying from CEO Ryan Cohen. The recent Q2 release and Ryan Cohen’s insider buying landed in a market that had already started to warm to GameStop, with a 30 day share price return of 26.85% and a 7 day gain of 11.67% on the way to a latest share price of $22.77. That short term momentum contrasts with a 1 year total...
NYSE:TRIN
NYSE:TRINCapital Markets

Insider Buying Highlights Undervalued Small Caps In September 2026

In the last week, the United States market has stayed flat, yet it is up 12% over the past year with earnings forecast to grow by 17% annually. In this context, identifying stocks that are potentially undervalued can be crucial for investors looking to capitalize on growth opportunities, particularly when insider buying signals confidence in a company's prospects.